share_log

Clearmind Medicine | SC 13G: Statement of acquisition of beneficial ownership by individuals-AdvisorShares Trust(5.48%)

SEC announcement ·  Feb 15 00:12
Summary by Futu AI
AdvisorShares Trust, an investment company registered under Section 8 of the Investment Company Act of 1940, has filed a Schedule 13G with the United States Securities and Exchange Commission on February 14, 2024, indicating a significant ownership stake in Clearmind Medicine Inc. The filing, which is required due to the event that occurred on December 31, 2023, shows that AdvisorShares Trust holds 92,693 common shares of Clearmind Medicine, representing 5.48% of the company's class of securities. The shares are held with sole voting and dispositive power, suggesting that AdvisorShares Trust has both the right to vote and the right to dispose of the shares. The address of Clearmind Medicine's principal executive offices is listed as 101 – 1220 W 6 Ave, Vancouver BC, Canada. The filing asserts that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Clearmind Medicine.
AdvisorShares Trust, an investment company registered under Section 8 of the Investment Company Act of 1940, has filed a Schedule 13G with the United States Securities and Exchange Commission on February 14, 2024, indicating a significant ownership stake in Clearmind Medicine Inc. The filing, which is required due to the event that occurred on December 31, 2023, shows that AdvisorShares Trust holds 92,693 common shares of Clearmind Medicine, representing 5.48% of the company's class of securities. The shares are held with sole voting and dispositive power, suggesting that AdvisorShares Trust has both the right to vote and the right to dispose of the shares. The address of Clearmind Medicine's principal executive offices is listed as 101 – 1220 W 6 Ave, Vancouver BC, Canada. The filing asserts that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Clearmind Medicine.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.